454 Life Sciences Corporation, subsidiary of CuraGen Corporation, has announced that its Genome Sequencer 20 system has been selected and purchased by Keygene N.V. to enable its proprietary Complexity ...

A study published this month in the journal Tissue Antigens reports that researchers at Roche Molecular Systems in Pleasanton, CA have used high-throughput sequencing technology from 454 Life Sciences ...